Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Chronic Pruritus: Bedside to Bench Perspectives
Description
The session on chronic pruritus at the AAD meeting commenced with opening remarks from Dr. Ethan Lerner, who noted the significance of the topic and the advancements in awareness surrounding itch disorders. Lerner introduced the session's agenda, highlighting various presentations from experts in the field. Brian Kim was set to discuss the physiology of itch, while Emily Cole would address methods for measuring itch. Steve Shoe would delve into the use of wearable sensors for monitoring, and Jeanette Murawski aimed to shed light on vulvar itch, an often overlooked issue. The session also planned to explore the itch associated with cancer therapies, particularly concerning immunotherapies and their adverse effects, including rash and itch. This discussion would touch on current research into the roles of regulatory and memory T cells in these processes. Lastly, Gil Josephovich would summarize future directions in the field. Lerner expressed excitement regarding the collective knowledge and developments that were being shared, marking a pivotal moment for the study of chronic itch.
View moreConclusions
- Chronic pruritus is a complex condition that requires a multidisciplinary approach to understand and treat.
- Recent advancements in wearable sensors provide new ways to measure and monitor itch symptoms.
- There is a need for more discussion and research on sensitive topics like vulvar itch, which are often overlooked.
- The itch associated with cancer treatments, particularly checkpoint inhibitors, presents significant challenges in patient management.
- Ongoing research into T cell regulation may provide insights into the mechanisms underlying chronic itch.
- There is a growing body of work aimed at developing new therapeutic options for managing itch effectively.